ID   CDK12_HUMAN             Reviewed;        1490 AA.
AC   Q9NYV4; A7E2B2; B4DYX4; B9EIQ6; O94978;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 2.
DT   22-JUL-2015, entry version 143.
DE   RecName: Full=Cyclin-dependent kinase 12;
DE            EC=2.7.11.22;
DE            EC=2.7.11.23;
DE   AltName: Full=Cdc2-related kinase, arginine/serine-rich;
DE            Short=CrkRS;
DE   AltName: Full=Cell division cycle 2-related protein kinase 7;
DE            Short=CDC2-related protein kinase 7;
DE   AltName: Full=Cell division protein kinase 12;
DE            Short=hCDK12;
GN   Name=CDK12; Synonyms=CRK7, CRKRS, KIAA0904;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=11683387;
RA   Ko T.K., Kelly E., Pines J.;
RT   "CrkRS: a novel conserved Cdc2-related protein kinase that colocalises
RT   with SC35 speckles.";
RL   J. Cell Sci. 114:2591-2603(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M.,
RA   Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-681 AND SER-685, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-57; TYR-73; SER-400;
RP   SER-423; THR-514; SER-681; SER-685 AND THR-692, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; SER-301; SER-303;
RP   SER-318; SER-323; SER-325; SER-332; SER-333; SER-334; SER-345;
RP   SER-383; SER-385; SER-400; SER-681; SER-685 AND THR-692, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   FUNCTION.
RX   PubMed=19651820; DOI=10.1093/carcin/bgp187;
RA   Iorns E., Martens-de Kemp S.R., Lord C.J., Ashworth A.;
RT   "CRK7 modifies the MAPK pathway and influences the response to
RT   endocrine therapy.";
RL   Carcinogenesis 30:1696-1701(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420; SER-423; SER-681;
RP   SER-685; THR-692 AND SER-1053, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236; SER-383; SER-385;
RP   SER-681; SER-685 AND THR-1244, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20952539; DOI=10.1101/gad.1968210;
RA   Bartkowiak B., Liu P., Phatnani H.P., Fuda N.J., Cooper J.J.,
RA   Price D.H., Adelman K., Lis J.T., Greenleaf A.L.;
RT   "CDK12 is a transcription elongation-associated CTD kinase, the
RT   metazoan ortholog of yeast Ctk1.";
RL   Genes Dev. 24:2303-2316(2010).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236; SER-249; SER-385;
RP   SER-400; SER-423; SER-681; SER-685; THR-893 AND SER-1083, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   CHROMOSOMAL REARRANGEMENT WITH ERBB2, AND POSSIBLE INVOLVEMENT IN
RP   GASTRIC CANCER.
RX   PubMed=21097718; DOI=10.1158/0008-5472.CAN-10-1749;
RA   Zang Z.J., Ong C.K., Cutcutache I., Yu W., Zhang S.L., Huang D.,
RA   Ler L.D., Dykema K., Gan A., Tao J., Lim S., Liu Y., Futreal P.A.,
RA   Grabsch H., Furge K.A., Goh L.K., Rozen S., Teh B.T., Tan P.;
RT   "Genetic and structural variation in the gastric cancer kinome
RT   revealed through targeted deep sequencing.";
RL   Cancer Res. 71:29-39(2011).
RN   [20]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=22012619; DOI=10.1101/gad.16962311;
RA   Blazek D., Kohoutek J., Bartholomeeusen K., Johansen E., Hulinkova P.,
RA   Luo Z., Cimermancic P., Ule J., Peterlin B.M.;
RT   "The Cyclin K/Cdk12 complex maintains genomic stability via regulation
RT   of expression of DNA damage response genes.";
RL   Genes Dev. 25:2158-2172(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236; SER-249; SER-274;
RP   SER-276; SER-301; SER-303; SER-310; SER-312; SER-332; SER-333;
RP   SER-334; SER-338; SER-423; SER-681; SER-685; THR-893 AND SER-1083, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423; SER-681 AND
RP   SER-685, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 714-1063 IN COMPLEX WITH THE
RP   ATP ANALOG ADP; TRANSITION STATE ANALOG AND CCNK, FUNCTION, CATALYTIC
RP   ACTIVITY, SUBUNIT, INTERACTION WITH CCNK, PHOSPHORYLATION AT THR-893,
RP   IDENTIFICATION BY MASS SPECTROMETRY, MUTAGENESIS OF ASP-877, AND
RP   ENZYME REGULATION.
RX   PubMed=24662513; DOI=10.1038/ncomms4505;
RA   Boesken C.A., Farnung L., Hintermair C., Merzel Schachter M.,
RA   Vogel-Bachmayr K., Blazek D., Anand K., Fisher R.P., Eick D.,
RA   Geyer M.;
RT   "The structure and substrate specificity of human Cdk12/Cyclin K.";
RL   Nat. Commun. 5:3505-3505(2014).
RN   [24]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-530; HIS-912; GLN-1189 AND
RP   LEU-1275.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Cyclin-dependent kinase that phosphorylates the C-
CC       terminal domain (CTD) of the large subunit of RNA polymerase II
CC       (POLR2A), thereby acting as a key regulator of transcription
CC       elongation. Regulates the expression of genes involved in DNA
CC       repair and is required for the maintenance of genomic stability.
CC       Preferentially phosphorylates 'Ser-5' in CTD repeats that are
CC       already phosphorylated at 'Ser-7', but can also phosphorylate
CC       'Ser-2'. Required for RNA splicing, possibly by phosphorylating
CC       SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly
CC       leading to affect the response to estrogen inhibitors.
CC       {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820,
CC       ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619,
CC       ECO:0000269|PubMed:24662513}.
CC   -!- CATALYTIC ACTIVITY: ATP + [DNA-directed RNA polymerase] = ADP +
CC       [DNA-directed RNA polymerase] phosphate.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Inhibited by the ATP analog flavopiridol,
CC       purvalanol A, purvalanol B, staurosporine and CR8.
CC       {ECO:0000269|PubMed:24662513}.
CC   -!- SUBUNIT: Interacts with CCNL1 and CCNL2 (By similarity). Interacts
CC       with CCNK. {ECO:0000250, ECO:0000269|PubMed:22012619,
CC       ECO:0000269|PubMed:24662513}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus speckle. Note=Colocalized
CC       with nuclear speckles throughout interphase.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NYV4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYV4-2; Sequence=VSP_030284;
CC       Name=3;
CC         IsoId=Q9NYV4-3; Sequence=VSP_040908, VSP_040909, VSP_040910;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:11683387}.
CC   -!- PTM: Phosphorylation at Thr-893 increases kinase activity.
CC       {ECO:0000269|PubMed:24662513}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving CDK12 may be a
CC       cause gastric cancer. Deletions within 17q12 region producing
CC       fusion transcripts with ERBB2, leading to CDK12-ERBB2 fusion
CC       leading to trunctated CDK12 protein not in-frame with ERBB2.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA74927.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF227198; AAF36401.1; -; mRNA.
DR   EMBL; AB020711; BAA74927.2; ALT_INIT; mRNA.
DR   EMBL; AK302645; BAG63886.1; -; mRNA.
DR   EMBL; AC009283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471152; EAW60577.1; -; Genomic_DNA.
DR   EMBL; BC140854; AAI40855.1; -; mRNA.
DR   EMBL; BC150265; AAI50266.1; -; mRNA.
DR   CCDS; CCDS11337.1; -. [Q9NYV4-1]
DR   CCDS; CCDS45666.1; -. [Q9NYV4-2]
DR   RefSeq; NP_055898.1; NM_015083.2. [Q9NYV4-2]
DR   RefSeq; NP_057591.2; NM_016507.3. [Q9NYV4-1]
DR   UniGene; Hs.416108; -.
DR   PDB; 4CXA; X-ray; 3.15 A; A/C=715-1052.
DR   PDB; 4NST; X-ray; 2.20 A; A/C=714-1063.
DR   PDB; 4UN0; X-ray; 3.15 A; C/D=715-1038.
DR   PDBsum; 4CXA; -.
DR   PDBsum; 4NST; -.
DR   PDBsum; 4UN0; -.
DR   ProteinModelPortal; Q9NYV4; -.
DR   SMR; Q9NYV4; 718-1048.
DR   BioGrid; 119715; 23.
DR   IntAct; Q9NYV4; 6.
DR   MINT; MINT-1191969; -.
DR   STRING; 9606.ENSP00000398880; -.
DR   PhosphoSite; Q9NYV4; -.
DR   BioMuta; CDK12; -.
DR   DMDM; 308153421; -.
DR   MaxQB; Q9NYV4; -.
DR   PaxDb; Q9NYV4; -.
DR   PRIDE; Q9NYV4; -.
DR   DNASU; 51755; -.
DR   Ensembl; ENST00000430627; ENSP00000407720; ENSG00000167258. [Q9NYV4-2]
DR   Ensembl; ENST00000447079; ENSP00000398880; ENSG00000167258.
DR   GeneID; 51755; -.
DR   KEGG; hsa:51755; -.
DR   UCSC; uc002hrw.4; human. [Q9NYV4-2]
DR   UCSC; uc010cvv.3; human. [Q9NYV4-1]
DR   CTD; 51755; -.
DR   GeneCards; GC17P037618; -.
DR   H-InvDB; HIX0013777; -.
DR   HGNC; HGNC:24224; CDK12.
DR   HPA; HPA008038; -.
DR   MIM; 615514; gene.
DR   neXtProt; NX_Q9NYV4; -.
DR   PharmGKB; PA165431656; -.
DR   eggNOG; COG0515; -.
DR   GeneTree; ENSGT00800000124088; -.
DR   HOGENOM; HOG000049118; -.
DR   HOVERGEN; HBG050852; -.
DR   InParanoid; Q9NYV4; -.
DR   KO; K08819; -.
DR   OMA; YSTRSHP; -.
DR   PhylomeDB; Q9NYV4; -.
DR   TreeFam; TF101060; -.
DR   BRENDA; 2.7.11.22; 2681.
DR   SignaLink; Q9NYV4; -.
DR   ChiTaRS; CDK12; human.
DR   GeneWiki; CRKRS; -.
DR   GenomeRNAi; 51755; -.
DR   NextBio; 55858; -.
DR   PRO; PR:Q9NYV4; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; Q9NYV4; -.
DR   CleanEx; HS_CRKRS; -.
DR   ExpressionAtlas; Q9NYV4; baseline and differential.
DR   Genevisible; Q9NYV4; HS.
DR   GO; GO:0002944; C:cyclin K-CDK12 complex; IPI:MGI.
DR   GO; GO:0019908; C:nuclear cyclin-dependent protein kinase holoenzyme complex; ISS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030332; F:cyclin binding; IPI:MGI.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004672; F:protein kinase activity; IDA:HGNC.
DR   GO; GO:0008353; F:RNA polymerase II carboxy-terminal domain kinase activity; IMP:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0070816; P:phosphorylation of RNA polymerase II C-terminal domain; IMP:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:HGNC.
DR   GO; GO:0043405; P:regulation of MAP kinase activity; IMP:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IEA:Ensembl.
DR   GO; GO:0008380; P:RNA splicing; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR002290; Ser/Thr_dual-sp_kinase.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding;
KW   Chromosomal rearrangement; Complete proteome; Kinase; mRNA processing;
KW   mRNA splicing; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1   1490       Cyclin-dependent kinase 12.
FT                                /FTId=PRO_0000085715.
FT   DOMAIN      727   1020       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     733    741       ATP.
FT   NP_BIND     814    819       ATP.
FT   COMPBIAS    407    413       Poly-Ala.
FT   COMPBIAS    535    540       Poly-Pro.
FT   COMPBIAS   1266   1280       Poly-Pro.
FT   ACT_SITE    859    859       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     756    756       ATP.
FT   BINDING    1040   1040       ATP.
FT   MOD_RES      57     57       Phosphothreonine.
FT                                {ECO:0000269|PubMed:18691976}.
FT   MOD_RES      73     73       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:18691976}.
FT   MOD_RES     236    236       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     249    249       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     274    274       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   MOD_RES     276    276       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     303    303       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     310    310       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   MOD_RES     312    312       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   MOD_RES     318    318       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES     325    325       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES     332    332       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     333    333       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     334    334       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES     338    338       Phosphoserine.
FT                                {ECO:0000269|PubMed:21406692}.
FT   MOD_RES     345    345       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648}.
FT   MOD_RES     383    383       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:19690332}.
FT   MOD_RES     385    385       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES     400    400       Phosphoserine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:20068231}.
FT   MOD_RES     420    420       Phosphoserine.
FT                                {ECO:0000269|PubMed:19369195}.
FT   MOD_RES     423    423       Phosphoserine.
FT                                {ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19369195,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   MOD_RES     514    514       Phosphothreonine.
FT                                {ECO:0000269|PubMed:18691976}.
FT   MOD_RES     681    681       Phosphoserine.
FT                                {ECO:0000269|PubMed:17081983,
FT                                ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19369195,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   MOD_RES     685    685       Phosphoserine.
FT                                {ECO:0000269|PubMed:17081983,
FT                                ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19369195,
FT                                ECO:0000269|PubMed:19690332,
FT                                ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24275569}.
FT   MOD_RES     692    692       Phosphothreonine.
FT                                {ECO:0000269|PubMed:18669648,
FT                                ECO:0000269|PubMed:18691976,
FT                                ECO:0000269|PubMed:19369195}.
FT   MOD_RES     893    893       Phosphothreonine.
FT                                {ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692,
FT                                ECO:0000269|PubMed:24662513}.
FT   MOD_RES    1053   1053       Phosphoserine.
FT                                {ECO:0000269|PubMed:19369195}.
FT   MOD_RES    1083   1083       Phosphoserine.
FT                                {ECO:0000269|PubMed:20068231,
FT                                ECO:0000269|PubMed:21406692}.
FT   MOD_RES    1244   1244       Phosphothreonine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   VAR_SEQ     349    349       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040908.
FT   VAR_SEQ    1205   1274       DMQNILAVLLSQLMKTQEPAGSLEENNSDKNSGPQGPRRTP
FT                                TMPQEEAAACPPHILPPEKRPPEPPGPPP -> ILWYMQRP
FT                                NCKTMGSWGQEPLGPAAQEQAFTGGAQLSLLLMENSIGGLQ
FT                                ESHQEGEEGEEFLTNPETSVS (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040909.
FT   VAR_SEQ    1254   1262       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10048485,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_030284.
FT   VAR_SEQ    1275   1490       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_040910.
FT   VARIANT     530    530       P -> A (in dbSNP:rs56121596).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041968.
FT   VARIANT     912    912       R -> H (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041969.
FT   VARIANT    1189   1189       L -> Q (in dbSNP:rs56362165).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041970.
FT   VARIANT    1275   1275       P -> L (in dbSNP:rs34070318).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041971.
FT   MUTAGEN     877    877       D->N: Abolishes kinase activity.
FT                                {ECO:0000269|PubMed:24662513}.
FT   CONFLICT    133    133       S -> G (in Ref. 4; BAG63886).
FT                                {ECO:0000305}.
FT   CONFLICT    268    268       S -> G (in Ref. 4; BAG63886).
FT                                {ECO:0000305}.
FT   CONFLICT    639    639       D -> G (in Ref. 1; AAF36401).
FT                                {ECO:0000305}.
FT   CONFLICT    737    737       T -> I (in Ref. 4; BAG63886).
FT                                {ECO:0000305}.
FT   CONFLICT    745    745       K -> R (in Ref. 1; AAF36401).
FT                                {ECO:0000305}.
FT   CONFLICT    822    822       G -> V (in Ref. 4; BAG63886).
FT                                {ECO:0000305}.
FT   CONFLICT   1195   1195       T -> M (in Ref. 1; AAF36401, 2; BAA74927
FT                                and 6; AAI50266). {ECO:0000305}.
FT   HELIX       724    726       {ECO:0000244|PDB:4NST}.
FT   STRAND      727    735       {ECO:0000244|PDB:4NST}.
FT   STRAND      737    746       {ECO:0000244|PDB:4NST}.
FT   TURN        747    749       {ECO:0000244|PDB:4NST}.
FT   STRAND      752    758       {ECO:0000244|PDB:4NST}.
FT   STRAND      762    764       {ECO:0000244|PDB:4CXA}.
FT   HELIX       769    778       {ECO:0000244|PDB:4NST}.
FT   STRAND      789    794       {ECO:0000244|PDB:4NST}.
FT   STRAND      802    804       {ECO:0000244|PDB:4CXA}.
FT   STRAND      809    814       {ECO:0000244|PDB:4NST}.
FT   STRAND      817    819       {ECO:0000244|PDB:4NST}.
FT   HELIX       820    826       {ECO:0000244|PDB:4NST}.
FT   HELIX       833    852       {ECO:0000244|PDB:4NST}.
FT   HELIX       862    864       {ECO:0000244|PDB:4NST}.
FT   STRAND      865    867       {ECO:0000244|PDB:4NST}.
FT   STRAND      873    875       {ECO:0000244|PDB:4NST}.
FT   STRAND      886    888       {ECO:0000244|PDB:4NST}.
FT   HELIX       899    901       {ECO:0000244|PDB:4NST}.
FT   HELIX       904    907       {ECO:0000244|PDB:4NST}.
FT   HELIX       916    931       {ECO:0000244|PDB:4NST}.
FT   HELIX       941    952       {ECO:0000244|PDB:4NST}.
FT   TURN        957    959       {ECO:0000244|PDB:4NST}.
FT   HELIX       961    965       {ECO:0000244|PDB:4NST}.
FT   TURN        967    971       {ECO:0000244|PDB:4NST}.
FT   HELIX       982    985       {ECO:0000244|PDB:4NST}.
FT   TURN        986    988       {ECO:0000244|PDB:4NST}.
FT   HELIX       991   1000       {ECO:0000244|PDB:4NST}.
FT   TURN       1005   1007       {ECO:0000244|PDB:4NST}.
FT   HELIX      1011   1014       {ECO:0000244|PDB:4NST}.
FT   HELIX      1018   1021       {ECO:0000244|PDB:4NST}.
FT   HELIX      1025   1027       {ECO:0000244|PDB:4NST}.
FT   STRAND     1035   1037       {ECO:0000244|PDB:4NST}.
FT   HELIX      1041   1045       {ECO:0000244|PDB:4NST}.
SQ   SEQUENCE   1490 AA;  164155 MW;  D6B04B998ECDE58E CRC64;
     MPNSERHGGK KDGSGGASGT LQPSSGGGSS NSRERHRLVS KHKRHKSKHS KDMGLVTPEA
     ASLGTVIKPL VEYDDISSDS DTFSDDMAFK LDRRENDERR GSDRSDRLHK HRHHQHRRSR
     DLLKAKQTEK EKSQEVSSKS GSMKDRISGS SKRSNEETDD YGKAQVAKSS SKESRSSKLH
     KEKTRKEREL KSGHKDRSKS HRKRETPKSY KTVDSPKRRS RSPHRKWSDS SKQDDSPSGA
     SYGQDYDLSP SRSHTSSNYD SYKKSPGSTS RRQSVSPPYK EPSAYQSSTR SPSPYSRRQR
     SVSPYSRRRS SSYERSGSYS GRSPSPYGRR RSSSPFLSKR SLSRSPLPSR KSMKSRSRSP
     AYSRHSSSHS KKKRSSSRSR HSSISPVRLP LNSSLGAELS RKKKERAAAA AAAKMDGKES
     KGSPVFLPRK ENSSVEAKDS GLESKKLPRS VKLEKSAPDT ELVNVTHLNT EVKNSSDTGK
     VKLDENSEKH LVKDLKAQGT RDSKPIALKE EIVTPKETET SEKETPPPLP TIASPPPPLP
     TTTPPPQTPP LPPLPPIPAL PQQPPLPPSQ PAFSQVPASS TSTLPPSTHS KTSAVSSQAN
     SQPPVQVSVK TQVSVTAAIP HLKTSTLPPL PLPPLLPGDD DMDSPKETLP SKPVKKEKEQ
     RTRHLLTDLP LPPELPGGDL SPPDSPEPKA ITPPQQPYKK RPKICCPRYG ERRQTESDWG
     KRCVDKFDII GIIGEGTYGQ VYKAKDKDTG ELVALKKVRL DNEKEGFPIT AIREIKILRQ
     LIHRSVVNMK EIVTDKQDAL DFKKDKGAFY LVFEYMDHDL MGLLESGLVH FSEDHIKSFM
     KQLMEGLEYC HKKNFLHRDI KCSNILLNNS GQIKLADFGL ARLYNSEESR PYTNKVITLW
     YRPPELLLGE ERYTPAIDVW SCGCILGELF TKKPIFQANL ELAQLELISR LCGSPCPAVW
     PDVIKLPYFN TMKPKKQYRR RLREEFSFIP SAALDLLDHM LTLDPSKRCT AEQTLQSDFL
     KDVELSKMAP PDLPHWQDCH ELWSKKRRRQ RQSGVVVEEP PPSKTSRKET TSGTSTEPVK
     NSSPAPPQPA PGKVESGAGD AIGLADITQQ LNQSELAVLL NLLQSQTDLS IPQMAQLLNI
     HSNPEMQQQL EALNQSISAL TEATSQQQDS ETMAPEESLK EAPSAPVILP SAEQTTLEAS
     STPADMQNIL AVLLSQLMKT QEPAGSLEEN NSDKNSGPQG PRRTPTMPQE EAAACPPHIL
     PPEKRPPEPP GPPPPPPPPP LVEGDLSSAP QELNPAVTAA LLQLLSQPEA EPPGHLPHEH
     QALRPMEYST RPRPNRTYGN TDGPETGFSA IDTDERNSGP ALTESLVQTL VKNRTFSGSL
     SHLGESSSYQ GTGSVQFPGD QDLRFARVPL ALHPVVGQPF LKAEGSSNSV VHAETKLQNY
     GELGPGTTGA SSSGAGLHWG GPTQSSAYGK LYRGPTRVPP RGGRGRGVPY
//
